How One Man’s Psychedelic Journey May Change the Face of Schizophrenia Treatment


CANNABIS CULTURE – “It is well understood that people with schizophrenia should not take large dosages of psychedelics because it is destabilizing,” says Mark Haden, Executive Director of the Multidisciplinary Association for Psychedelic Studies (MAPS) in Canada.  “But we don’t know the effect of small dosages and how that can impact them.” The future of psychosis treatment took a new turn when Haden met a young man named “John Doe,” who had experience in microdosing…


Source link

Leave a Reply

Your email address will not be published. Required fields are marked *